The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As human aging, 50% of women will be faced with the threat of cancer, especially gynecological malignancies. Ovarian, cervical and endometrial cancer are three major gynecological malignancies. In recent years, the incidence of cervical cancer, especially in young women significantly increased; ovarian cancer, although the incidence of malignant tumors in the female reproductive system ranked second, but its mortality rate already in the first place; and the morbidity and mortality of endometrial cancer is also rising.

The key to gynecologic malignancies is how to early diagnose and treat. With the advancement of science and technology, such as molecular biology techniques widely used in the medical field, early diagnosis, proper treatment and other aspects in gynecologic malignancies is expected to achieve a breakthrough. Genome-wide scan strategy, making the whole genome for linkage analysis for gynecological malignancies possible. Therefore, the investigators intend to find specific mutations to provide a new early screening approach for gynecological malignancies, which in later result in early diagnosis and specific treatment for gynecological malignant tumors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collecting Tumor Samples From Patients With Gynecological Tumors

NCT00897442

Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Cervical Adenocarcinoma +83 more

COMPLETED

Investigations of Reproductive Cancers in Women

NCT06527157

Uterine Cancer

RECRUITING

Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma

NCT05273099

Cancer of Endometrium

UNKNOWN

Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study

NCT04214964

Gynecologic Cancer Ovarian Cancer Endometrial Cancer +1 more

UNKNOWN

A Cohort Study of Uterine Malignancies

NCT05635123

Cervical Cancer Endometrial Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gynecologic Malignant Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experiment group

patients with cervical cancer, endometrial cancers or ovary cancer

No interventions assigned to this group

control group

postmenopausal women with benign tumor

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female aging from 16 to 75-year old;
* Preoperative diagnosis of gynecologic malignancies;
* Have the ability to comply with Research programs;
* Voluntarily participate in the study and signed an informed consent form

Minimum Eligible Age

16 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes